These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 18245173)
1. A role for ceramide in driving cancer cell resistance to doxorubicin. Liu YY; Yu JY; Yin D; Patwardhan GA; Gupta V; Hirabayashi Y; Holleran WM; Giuliano AE; Jazwinski SM; Gouaze-Andersson V; Consoli DP; Cabot MC FASEB J; 2008 Jul; 22(7):2541-51. PubMed ID: 18245173 [TBL] [Abstract][Full Text] [Related]
2. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells. Uchida Y; Itoh M; Taguchi Y; Yamaoka S; Umehara H; Ichikawa S; Hirabayashi Y; Holleran WM; Okazaki T Cancer Res; 2004 Sep; 64(17):6271-9. PubMed ID: 15342415 [TBL] [Abstract][Full Text] [Related]
3. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385 [TBL] [Abstract][Full Text] [Related]
4. Ceramide glycosylation potentiates cellular multidrug resistance. Liu YY; Han TY; Giuliano AE; Cabot MC FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390 [TBL] [Abstract][Full Text] [Related]
5. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling. Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746 [TBL] [Abstract][Full Text] [Related]
6. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281 [TBL] [Abstract][Full Text] [Related]
7. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. Liu YY; Han TY; Giuliano AE; Cabot MC J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062 [TBL] [Abstract][Full Text] [Related]
8. Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells. Liu YY; Han TY; Yu JY; Bitterman A; Le A; Giuliano AE; Cabot MC J Lipid Res; 2004 May; 45(5):933-40. PubMed ID: 14967819 [TBL] [Abstract][Full Text] [Related]
9. Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance. Liu YY; Hill RA; Li YT Adv Cancer Res; 2013; 117():59-89. PubMed ID: 23290777 [TBL] [Abstract][Full Text] [Related]
10. Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma. Stefanovic M; Tutusaus A; Martinez-Nieto GA; Bárcena C; de Gregorio E; Moutinho C; Barbero-Camps E; Villanueva A; Colell A; Marí M; García-Ruiz C; Fernandez-Checa JC; Morales A Oncotarget; 2016 Feb; 7(7):8253-67. PubMed ID: 26811497 [TBL] [Abstract][Full Text] [Related]
11. The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs. Veldman RJ; Mita A; Cuvillier O; Garcia V; Klappe K; Medin JA; Campbell JD; Carpentier S; Kok JW; Levade T FASEB J; 2003 Jun; 17(9):1144-6. PubMed ID: 12692077 [TBL] [Abstract][Full Text] [Related]
12. A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis. Patwardhan GA; Zhang QJ; Yin D; Gupta V; Bao J; Senkal CE; Ogretmen B; Cabot MC; Shah GV; Sylvester PW; Jazwinski SM; Liu YY PLoS One; 2009 Sep; 4(9):e6938. PubMed ID: 19742320 [TBL] [Abstract][Full Text] [Related]
13. MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells. Zhang X; Wu X; Li J; Sun Y; Gao P; Zhang C; Zhang H; Zhou G J Surg Oncol; 2011 Oct; 104(5):466-71. PubMed ID: 21538359 [TBL] [Abstract][Full Text] [Related]
14. Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells. Liu YY; Patwardhan GA; Bhinge K; Gupta V; Gu X; Jazwinski SM Cancer Res; 2011 Mar; 71(6):2276-85. PubMed ID: 21278235 [TBL] [Abstract][Full Text] [Related]
15. A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer. Madigan JP; Robey RW; Poprawski JE; Huang H; Clarke CJ; Gottesman MM; Cabot MC; Rosenberg DW Exp Cell Res; 2020 Mar; 388(2):111860. PubMed ID: 31972222 [TBL] [Abstract][Full Text] [Related]
16. Glucosylceramide synthase, a factor in modulating drug resistance, is overexpressed in metastatic breast carcinoma. Liu YY; Patwardhan GA; Xie P; Gu X; Giuliano AE; Cabot MC Int J Oncol; 2011 Aug; 39(2):425-31. PubMed ID: 21617856 [TBL] [Abstract][Full Text] [Related]
17. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells. Gouazé-Andersson V; Yu JY; Kreitenberg AJ; Bielawska A; Giuliano AE; Cabot MC Biochim Biophys Acta; 2007 Dec; 1771(12):1407-17. PubMed ID: 18035065 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137 [TBL] [Abstract][Full Text] [Related]
19. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis. Liu YY; Han TY; Giuliano AE; Ichikawa S; Hirabayashi Y; Cabot MC Exp Cell Res; 1999 Nov; 252(2):464-70. PubMed ID: 10527636 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine-phosphorylation and activation of glucosylceramide synthase by v-Src: Its role in survival of HeLa cells against ceramide. Honda T; Motoyoshi K; Kasahara J; Yamagata K; Takahashi H; Nakamura H; Murayama T Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158817. PubMed ID: 32980536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]